View More Recent Stories

Mar 8, 2021 06:00AM Greenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to Manage Phase III Clinical Trial for Recurring Breast Cancer
Mar 2, 2021 06:00AM Greenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring Conferences
Dec 11, 2020 06:36AM Greenwich LifeSciences (GLSI) Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer
Dec 11, 2020 06:00AM Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer
View More Recent Stories